CIOReview
CIOREVIEW >> Manufacturing >>

Charles Lickfold Joins Catalent as Chief Information Officer

By CIOReview | Tuesday, August 11, 2020

Catalent appointment of Charles Lickfold as CIO to lead its digital transformation and automation strategy.

FREMONT, CA: Catalent, the global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announces the appointment of Charles Lickfold as Senior Vice President, Chief Information Officer. Mr. Lickfold succeeds John McGill, who, following a period of transition, plans to retire in September 2020. He will report to Alessandro Maselli, the company's President and Chief Operating Officer.

Charles Lickfold will be responsible for Catalent's global IT services and technology, overseeing every aspect of information technology service and functions at the company's network of facilities around the world. Besides, Mr. Lickfold will head the company's continuing digital transformation and automation strategy while making sure that the most rigorous data integrity standards are met.

With more than 20 years of experience in digital and information technology, Mr. Lickfold has a proven record of significant IT leadership in the pharmaceutical services industry. Before joining Catalent, he held several leadership positions, including Chief Information Officer at Alcami, Avara Pharmaceutical Services, and Gilbarco Veeder-Root. He also served as Vice President and Head of IT for Patheon. Lickfold's deep expertise in both applications and infrastructure across diverse IT environments includes extensive work in the areas of IT transformation, business change programs, and corporate mergers and acquisitions. Mr. Lickfold began his career as a management consultant in the life sciences practice of Ernst & Young LLP after bagging his bachelor's degree in computer science from the University of Kentucky's College of Engineering.

Catalent is a deliverer of advanced technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products. With over 85 years of experience, the company has expertise in bringing customer products to market faster, improving product performance, and ensuring reliable clinical and commercial product supply.